NeuroMetrix Launches the LivingQuell Blog, a New Platform for Exploring Perspectives on Chronic Pain

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

NeuroMetrix, Inc. (Nasdaq: NURO) today announced the launch of LivingQuell, a blog that will serve as an online resource for people affected by chronic pain – as well as the rapidly growing user base of the company’s Quell® Wearable Pain Relief Technology™.

With an estimated one in three Americans living with chronic pain, NeuroMetrix aims to create an online space to share new ideas and content, and bring together all who are impacted. LivingQuell will cover a variety of topics for those living with pain, their loved ones, caregivers, clinicians and beyond. It will also include perspectives on industry news, viewpoints from pain management and sleep healthcare professionals, and real stories from Quell users. Blog readers can also expect to learn about alternative treatments to opioids and emerging drug-free therapies, which are becoming more essential to managing chronic pain.

“Over the last 20 years at NeuroMetrix, we’ve maintained the practice of being customer-centric. We listen to our users and make improvements to our products in response to their feedback,” said Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix. “A blog that supports our customers in new ways with content from their peers as well as experts was a logical next step in our mission. Our hope is for LivingQuell to bring greater awareness, insight and education to the broader chronic pain conversation and to Quell users.”

Alongside the launch of the LivingQuell blog, NeuroMetrix is also introducing a Quell Ambassador program. “We regularly connect with our users and chronic pain influencers, and they all have unique experiences and perspectives to share,” said Frank McGillin, Senior Vice President and Chief Commercial Officer at NeuroMetrix. “Our Ambassador program offers a new way for them to participate in important conversations and share their personal stories about chronic pain. This also allows users whose lives have been impacted by Quell to influence future decisions about product innovation.”

Recently, NeuroMetrix welcomed a group of 30 users local to its Waltham, Mass. headquarters to “meet the makers,” learn about upcoming Quell product features and share their stories and feedback on the product. Quell users were able to learn more about product development directly from Dr. Gozani, and connect with peers and NeuroMetrix’s customer care, engineering and marketing teams. Through the Quell Ambassador program, NeuroMetrix intends to host more of these events. Find blog here.



Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.